Expertise in
21
conditions

Wuh-liang J. Hwu

7 Chung Shan S. Road, 
TPQ, TW 
Expertise in
21
conditions
7 Chung Shan S. Road, 
TPQ, TW 
OverviewLocationsClinical Research

Overview

Wuh-liang Hwu practices in Taiwan. Hwu is highly rated in 21 conditions, according to our data. Their top areas of expertise are Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency, Pompe Disease, Mucolipidosis Type 4, and Citrullinemia.

Their clinical research consists of co-authoring 209 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

7 Chung Shan S. Road, TPQ, Taiwan
Other Locations
No. 7 Chung Shan South Road, TPQ 10002, Taiwan
2 Yude Road, 404, Taitung, TNQ, Taiwan
No. 8, Chung Shan S. Rd, Zhongzheng Dist, TPQ 10041, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-Label Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ISIS 396443 Delivered Intrathecally to Subjects With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
An Open-Label Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ISIS 396443 Delivered Intrathecally to Subjects With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: Nusinersen
Study Phase: Phase 2
A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
Enrollment Status: Completed
Publish Date: February 10, 2023
Intervention Type: Drug
Study Drug: Adeno-Associated Virus Serotype 2 AADC Vaccine
Study Phase: Phase 1/Phase 2
A Multi-Center, Open-Label Study Evaluating Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Enzyme Replacement Therapy
A Multi-Center, Open-Label Study Evaluating Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Enzyme Replacement Therapy
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Biological
Study Phase: Phase 4
View 2 Less Clinical Trials

209 Total Publications

Plasma Glial Fibrillary Acidic Protein Correlates With Brain Metal Burden in Wilson's Disease.
Plasma Glial Fibrillary Acidic Protein Correlates With Brain Metal Burden in Wilson's Disease.
Journal: Annals of clinical and translational neurology
Published: June 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hwu's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 75 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile